🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

10+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 10 of 10 recruiting trials for “alazami-syndrome”

RecruitingNCT07293897 ↗

A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

👨‍⚕️ Study Director, Takeda📍 1 site📅 Started Jan 2026View details ↗
Phase 4RecruitingNCT07290257 ↗

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)

🏥 Mirum Pharmaceuticals, Inc.📍 13 sites📅 Started Sep 2025View details ↗
RecruitingNCT06850038 ↗

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

👨‍⚕️ Ipsen Medical, Director, Ipsen📍 8 sites📅 Started Apr 2025View details ↗
Phase 4RecruitingNCT06499948 ↗

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)

🏥 Stefan Lujinschi📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06193928 ↗

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

🏥 Mirum Pharmaceuticals, Inc.📍 8 sites📅 Started Sep 2023View details ↗
RecruitingNCT06526741 ↗

ASF Alport Patient Registry

👨‍⚕️ Benjamin A Weinstock, PhD, Alport Syndrome Foundation📍 1 site📅 Started Aug 2023View details ↗
Phase 3RecruitingNCT05035030 ↗

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

👨‍⚕️ Ipsen Medical Director, Ipsen📍 20 sites📅 Started Sep 2021View details ↗
RecruitingNCT04947813 ↗

Genotype-Phenotype Correlations in Patients With Alport Syndrome

🏥 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2021View details ↗
RecruitingNCT05927467 ↗

Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

👨‍⚕️ Laurence Heidet, PHD, INSERM U933📍 1 site📅 Started May 2017View details ↗
RecruitingNCT02378805 ↗

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

👨‍⚕️ Oliver Gross, MD, University Hospital Goettingen📍 1 site📅 Started Jul 1995View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →